slide

Alnylam stock rises on strong results in heart drug study 1 minute ago Shares of Alnylam Pharmaceuticals ( ALNY ) skyrocketed after the biopharma firm reported strong results from a late-stage study of its RNA interference drug for a rare heart disease. The company reported that a Phase 3 trial of its vutrisiran showed “a … Read more